Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9-10
|
| pubmed:dateCreated |
1998-10-9
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0264-410X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
871-2
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9682329-Chile,
pubmed-meshheading:9682329-Clinical Trials as Topic,
pubmed-meshheading:9682329-Humans,
pubmed-meshheading:9682329-Polysaccharides, Bacterial,
pubmed-meshheading:9682329-Salmonella typhi,
pubmed-meshheading:9682329-South Africa,
pubmed-meshheading:9682329-Typhoid Fever,
pubmed-meshheading:9682329-Typhoid-Paratyphoid Vaccines
|
| pubmed:articleTitle |
Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply.
|
| pubmed:publicationType |
Letter
|